DCOYDecoy Therapeutics Inc. · Nasdaq Capital Market · $3.85 · $2.52M mkt cap
Assessed Sep 1, 2026 · Reassessment
Is the float you're seeing correct?
636.5K
Estimated float

Outstanding (655,185 per 10-Q cover 2026-08-11) less actual ISSUED insider common (3,114).

Understated 12%
570.8K
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 636.5K shares.

Dilution risk8/10HIGH
CONFIDENCE: MEDIUM

The float your screener shows is understated 12%: 570.8K reported, 636.5K actual. 2 convertible notes and 5 reverse splits can add another 911% of the float.

  • Near-zero-strike pre-funded warrant overhang held by a single fund. Armistice Capital holds 469,000 unexercised pre-funded warrants struck at $0.0001 — economically identical to already-issued stock — equal to 73.7% of the current 636,498-share float.

  • Registered resale shares vastly exceeding outstanding stock. S-1 333-297381 went effective 2026-07-17 registering 3,766,500 shares for resale against 531,968 then outstanding — 7.1x the entire share count.

  • Variable-rate equity line with no exchange cap and an anti-dilution reset. The C/M Capital equity line prices at 95% of the LESSER of the prior day's closing price or VWAP — a floorless, market-referenced formula that issues more shares as the price falls.

From today's float to the ceiling

shares
636.5K
Estimated float
tradeable today
+469.0K can sell now
1.11M
Effective supply
float plus what sells on notice
+5.35M if floors are cut and warrants exercise
6.45M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
636.5K
Can sell now
Warrants in the money, at or near a zero strike
Exercisable at or below the current tape.
+469.0K
Effective supply
1.11M
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling. Includes unfunded commitments, which are capacity rather than outstanding debt.
$5.14M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+498.7K
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+4.03M
Options and RSUs
Employee equity; vests and settles over time.
+13.7K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+802.5K
Fully diluted
6.45M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
$3.85
Market cap
$2.52M
Shares outstanding
655.2K
Reported float
570.8K
Avg volume
10.57M
Reverse splits
5 · latest 1-for-12 · Mar 6, 2026
Going concern
Yes · 2.4 quarters runway
Quarterly burn
$2.30M

Market data as of Sep 23, 2026

Key dates

  • Dec 23, 2026 · 180-day variable-rate transaction standstill from the 2026-06-26 PIPE expires — C/M Capital ELOC (~$5.0M undrawn, floorless 5% discount, no exchange cap) and t…
  • Dec 29, 2026 · 213,198 placement agent warrants at $7.3875 become exercisable as the FINRA 5110 lock-up lapses
  • Mar 31, 2027 · Nasdaq mandatory panel monitor expires — until then the company cannot use a 180-day bid-price cure period and must resolve any deficiency by other means, hist…
DCOY Float & Dilution Analysis | ShareStructure.io